Skip to main content
Content for healthcare professionals only
Radcliffe Group
Cardiology
Vascular
Medical Education
Register for FREE
Log In
View all Platforms
Cardiology
Topics
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
Events
Upcoming Events
Radcliffe Events
All Events
Resource Hubs
Empagliflozin in the Treatment of Chronic Heart Failure
Radcliffe Platforms
Radcliffe Group
Cardiology
Vascular
Medical Education
Register for FREE
Log In
Content for healthcare professionals only
Topics
Featured
Advancement in Heart Failure
Amyloidosis
Cardiomyopathy
Cardio-oncology
Diabetes
Hypertension Management
Nonalcoholic Steatohepatitis (NASH)
Obesity
Pulmonary Embolism
Stroke Prevention in Atrial Fibrillation
Sudden Cardiac Death
Anticoagulation
COVID-19
CV Disease in Special Populations
Demographic
Digital Health
Electrophysiology & Arrhythmia
Heart Failure
Heterogeneous Populations
Imaging & Diagnostics
Intervention
MI / ACS
Pericardium Disorders
Prevention & Chronic Conditions
Standards & Guidelines
Vascular Disease & Surgery
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
View All
Juan Carlos Kaski
Peter O'Kane
Ankur Kalra
Angelo Auricchio
Harriette Van Spall
Andrew Coats
Mirvat Alasnag
Arjun Ghosh
Demos Katritsis
Nicolas Van Mieghem
Joost Daemen
Carolyn Lam
Events
Upcoming Events
Radcliffe Events
All Events
Resource Hubs
Empagliflozin in the Treatment of Chronic Heart Failure
Breadcrumb
Home /
News Index
Latest News
Written by:
ESC Congress, Radcliffe Cardiology
ESC Congress 2024 Reveals its Late-Breaking Scientific Sessions
11 July 2024
Written by:
Radcliffe Cardiology, ESC Congress
ESC Congress 2024 Unveils its Hot Line Trials
09 July 2024
Written by:
Radcliffe Cardiology, Greg Guillory, Jordan Rance, Mirjam Boros
Novel Agent Data for Obesity Released at ADA 2024 Scientific Sessions Show Benefits for Glycaemic and Blood…
25 June 2024
Written by:
Radcliffe Cardiology, Greg Guillory, Mirjam Boros
FLOW Trial Analysis: Deep Dive into the SGLT2-GLP-1 Combination Therapy
25 June 2024
Written by:
Radcliffe Cardiology, Greg Guillory, Mirjam Boros
SURMOUNT-OSA: Tirzepatide Significantly Improves Sleep Apnea and Cardiometabolic Risk Factors
24 June 2024
Written by:
Radcliffe Cardiology, Mirjam Boros ; Special Editor: Greg Guillory
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors
31 May 2024
Written by:
European Renal Association
Semaglutide May Protect Kidney Function in Individuals with Overweight or Obesity and Cardiovascular Disease
28 May 2024
Written by:
HRS Conference, Radcliffe Cardiology
Heart Rhythm 2024 Unveils its Late Breaking Trial Program
24 April 2024
Written by:
SCAI 2024, Radcliffe Cardiology
Featured Clinical Research to be Presented at SCAI 2024
24 April 2024
Written by:
EuroPCR 2024, Radcliffe Cardiology
EuroPCR Congress 2024 Reveals its Late-Breaking Clinical Trial Presentations
23 April 2024
Load More
External news
Written by:
Cardiovascular Business
Cardiology groups push for Medicare reform in face of ‘unsustainable’ payment cuts
27 July 2024
Written by:
Cardiovascular Business
Edwards Lifesciences agrees to acquire JenaValve, Endotronix for $1.2B
27 July 2024
Written by:
Cardiovascular Business
Why electrophysiology trials need to include more women
27 July 2024
Written by:
Medscape
Jul 26 2024 This Week in Cardiology
26 July 2024
Written by:
Cardiac Vascular News
Acticor Biotech Announces the Conclusions of the Interim Futility Analysis in the GREEN Study
26 July 2024
Written by:
Cardiac Vascular News
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
26 July 2024
Written by:
Medscape
Low Rates of Pediatric Lipid Screening in the United States
26 July 2024
Written by:
Cardiovascular Business
Cardiology Funding Roundup: Cardurion, Kestra, TRiCares all secure key investments
26 July 2024
Written by:
Cardiovascular Business
Artificial blood vessels could limit risks during heart bypass procedures
26 July 2024
Written by:
Cardiovascular Business
Texas surgeons first in world to perform ‘groundbreaking’ total artificial heart procedure
26 July 2024
Load More